PRINCETON, N.J., March 17 /PRNewswire-FirstCall/ -- Rockwood Holdings, Inc. (“Rockwood”) announced today that its subsidiary Groupe Novasep is collaborating with Roche to fulfill the exceeding market demands for Tamiflu(R) flu medicine.
The manufacturing of Tamiflu(R) (Oseltamivir) is complex and consists of several intermediate steps.
Groupe Novasep is involved as a custom manufacturer in the production of the sensitive Azide intermediate in one of its affiliates: Dynamit Nobel GmbH ES. As the world leader in Azide chemistry, Groupe Novasep provides the right know-how and specific technology. Groupe Novasep offers capacity in the specially constructed and equipped plant of Dynamit Nobel GmbH ES, where the sensitive Azide intermediate is produced in high quantities, to meet time and quality requirements.
Groupe Novasep, headquartered in Pompey, France, combines chemical synthesis and chemical engineering expertise in order to develop new technologies. The Group operates through two business units: Novasep Synthesis and Novasep Process, focusing on the synthesis and process of active pharmaceutical and biopharmaceutical ingredients.
Rockwood Holdings, Inc. is the ultimate parent company of Rockwood Specialties Group, Inc., a leading global specialty chemicals and advanced materials company. Rockwood has a worldwide employee base of approximately 10,800 people and net revenue of approximately $2.9 billion in 2004 on a pro forma basis. The company focuses on global niche segments of the specialty chemicals and advanced materials markets, including specialty chemicals, performance additives, titanium dioxide pigments, advanced ceramics, custom synthesis, specialty compounds and electronics. For more information on Rockwood, please visit http://www.rocksp.com.
Tamiflu(R) is a registered trademark of Roche.
The information set forth in this press release contains certain “forward- looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the business, operations and financial condition of Rockwood Holdings, Inc., its subsidiaries and affiliates (“Rockwood”). Words such as “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “predicts” and variations of such words or expressions are intended to identify forward-looking statements. Although Rockwood believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. “Forward-looking statements” consist of all non-historical information, including the statements referring to the prospects and future performance of Rockwood. Actual results could differ materially from those projected in Rockwood’s forward-looking statements due to numerous known and unknown risks and uncertainties, including, among other things, the “Risk Factors” described in Rockwood’s securities filings with the Securities and Exchange Commission, including its registration statement on Form S-1. Rockwood does not undertake any obligation to publicly update any forward- looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
Rockwood Holdings, Inc.
CONTACT: Kristin Campbell, kristin@hbmadv.com, or Camille Dager,camille@hbmadv.com, both of HB&M for Rockwood, +1-215-440-9800
Web site: http://www.rocksp.com/
